saxenda glp 1 agonist Novo Nordisk announces Saxenda® (liraglutide [rDNA origin] injection) is now commercially available in the United States Glucagon-like peptide-1 receptor agonists (GLP-1RAs)
Pay in 4 interest-free payments of $6.11 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Nov 9 - Nov 14
![saxenda glp 1 agonist Novo Nordisk announces Saxenda (liraglutide [rDNA origin] injection) is now commercially available in the United States Glucagon-like peptide-1 receptor agonists (GLP-1RAs)](https://insights.citeline.com/resizer/v2/TSZ7GUC53NHWVPONFRWK5ATONE.jpg?smart=true&auth=63b90fd60c1f7cd8d70dec77ef6e370667db1ebf65eb042c406b01746595fece&width=700&height=394)
![saxenda glp 1 agonist Novo Nordisk announces Saxenda (liraglutide [rDNA origin] injection) is now commercially available in the United States Glucagon-like peptide-1 receptor agonists (GLP-1RAs)](https://www.ccthaitown.com/wp-content/uploads/2020/08/014-2.jpg)
![saxenda glp 1 agonist Novo Nordisk announces Saxenda (liraglutide [rDNA origin] injection) is now commercially available in the United States Glucagon-like peptide-1 receptor agonists (GLP-1RAs)](https://www.novomedlink.com/obesity/products/treatments/saxenda/_jcr_content/root/slab/content/container/image_copy_copy_copy_586929311.img.png/1747953702040/saxenda-pen.png)


.png&w=828&q=100)


















